510(k) Report

510(k) · Cleared

Cleared

Rempress and Angiography Contrast Delivery System Rempress

K092896510(k) TraditionalCleared Oct 29, 2010403-day reviewClass II21 CFR 870.1650

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Nemoto Kyorindo Co., Ltd. · DXT Injector And Syringe, Angiographic

Cleared on Oct 29, 2010 as substantially equivalent to K963071 (Mallinckrodt Inc., Liebel-Flarsheim Business, 1997) and 1 other predicate after a 403-day review. Its family tree reaches back 2 generations to 1986. 1 later device descends from it.

Decided
Oct 29, 2010
Review
403 days
Class
Class II
Product code
DXT
Recalls
None
Predicates
2

Its longest line of descent runs back 2 generations to K860204 (1986). 3 ancestors in all. 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 1992: 1 other ancestor2018: 1 descendant clearedK860204 · Angiomat 6000 · Mallinckrodt Group, Inc. · 1986K963071 · Angiomat Illumena · Mallinckrodt Inc., Liebel-Flarsheim Business · 1997 · recalled1990200020102020
Other ancestors, by generationDescendants, by generation 2 generations back: 1 other ancestor 1 generation forward: 1 descendant K963071 · Angiomat Illumena · Mallinckrodt Inc., Liebel-Flarsheim Business · 1997 · recalledK860204 · Angiomat 6000 · Mallinckrodt Group, Inc. · 19860
  1. Root · 2 generations backK860204 Angiomat 6000Mallinckrodt Group, Inc. · 1986
  2. 1 generation backK963071 Angiomat IllumenaMallinckrodt Inc., Liebel-Flarsheim Business · 1997 · Recalled
  3. This deviceK092896 Rempress and Angiography Contrast Delivery System RempressNemoto Kyorindo Co., Ltd. · 2010
  4. Descendant · cites it directly · 0 of its ownK173450 PRESS DUO elite, PRESS DUO elite AGNemoto Kyorindo Co., Ltd. · 2018

Most influential descendants

Showing 1 of 1 · See all
  • K173450PRESS DUO elite, PRESS DUO elite AGNemoto Kyorindo Co., Ltd. · 2018 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K860204Angiomat 6000Mallinckrodt Group, Inc.1986—
−1K963071Angiomat IllumenaMallinckrodt Inc., Liebel-Flarsheim Business19972
0 (this device)K092896Rempress and Angiography Contrast Delivery System RempressNemoto Kyorindo Co., Ltd.2010—
+1K173450PRESS DUO elite, PRESS DUO elite AGNemoto Kyorindo Co., Ltd.2018—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199210

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201810
FIG. 1 — Lineage of K092896, 1986–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DXT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DXT device

  1. #1 K253048 High Pressure Syringe; Pressure Connecting…score 13.6 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K963071Angiomat Illumena
Summary page 1
…Injector System Classification Name: Injector and Syringe, Angiographic Predicate Device(s): Angiomat Illumena Injector, K963071 Angiomat 6000 Injector, K860204 Intended Use:…
Mallinckrodt Inc., Liebel-Flarsheim Business19972
*K860204Angiomat 6000
Summary page 1
…Injector and Syringe, Angiographic Predicate Device(s): Angiomat Illumena Injector, K963071 Angiomat 6000 Injector, K860204 Intended Use: injection system intended for the administration Th…
Mallinckrodt Group, Inc.1986—

Also cleared against K963071: 2 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K173450PRESS DUO elite, PRESS DUO elite AGNemoto Kyorindo Co., Ltd.20180

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 24 years and passes through 3 companies; a new generation was cleared every 13.1 years on median.
  • 2 of the 3 ancestors have a recall of any class.
  • Of its descendants, K173450 (Nemoto Kyorindo Co., Ltd., 2018) has gone furthest, with 0 descendants of its own.
  • 2 other devices also cite its predicate K963071.

How does its category compare?

All DXT devices

DXT Injector And Syringe, Angiographic: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · DXT

1in 2025

2007: 32008: 22009: 62010: 12011: 42013: 22014: 62015: 72016: 82017: 72018: 92019: 42020: 32021: 12023: 12024: 42025: 12026 (partial year): 7
2007high 9 (2018) · low 0 (2012)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DXT

138in 2024

2007: 182 days median2009: 137 days median2011: 69 days median2014: 144 days median2015: 153 days median2016: 172 days median2017: 183 days median2018: 93 days median2019: 96 days median2020: 154 days median2024: 138 days median2026 (partial year): 264 days median
2007high 264 (2026) · low 69 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DXT

10in 2024

2007: 42008: 32009: 72010: 32011: 32012: 72015: 12018: 22020: 12021: 12023: 22024: 102026 (partial year): 6
2007high 10 (2024) · low 0 (2013)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DXT

97in 2025

2007: 1072008: 1682009: 1882010: 1242011: 1332012: 1352013: 1412014: 972015: 1352016: 1522017: 1282018: 1292019: 1212020: 932021: 1322022: 1112023: 1172024: 1182025: 97
2007high 188 (2009) · low 93 (2020)2025

MAUDE reports naming product code DXT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200731824107
20082—3168
200961377188
20101—3124
20114693133
20120—7135
20132—0141
20146144097
201571531135
201681720152
201771830128
20189932129
20194960121
20203154193
20211—1132
20220—0111
20231—2117
2024413810118
20251—097
202672646—

What is it indicated for?

The contrast delivery system REMPRESS is an intravascular injection system intended for the administration of contrast media or normal saline used in conjunction with angiographic imaging procedures.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K092896: Rempress and Angiography Contrast Delivery System Rempress.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K092896

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026